Synosia Starts Phase II Efficacy Trial For Rufinamide
Added: 07 мая 2008
Last relative articles:
- Multicellular Response Is 'All For One'
- Low-Level Stress Reduced By Nature, Not Technology
- Stress In Pregnancy Affects Baby's Immune System
- Stress At Work Increases The Progression Of Arteriosclerosis
- Mother's Prenatal Stress Predisposes Their Babies To Asthma And Allergy
- Anxiety In Overweight Children Compounds Risk Factors
- Institute For Progressive Medicine Announces Deep Stress Relief Through Intravenous Vitamin Therapy
- Smart Sex, Less Stress Are Keys To Great Health, Women Say
- Reported Cases Of PTSD In Soldiers Up 50 In 2007, According To Defense Officials
- LUNESTA R Study Of Patients With Insomnia And Co-Morbid Generalized Anxiety Disorder GAD Published In Archives Of General Psychiatry
Comments: [0] / Post comment:
05 Jan 2009 22:19:50
Thriving in 2008: Approvals, Deals and Other Silver Linings - TMCnet
Thriving in 2008: Approvals, Deals and Other Silver Linings TMCnet - 14 for Banzel ( rufinamide ) as an adjunctive treatment for seizures in adults and children older than 4 years with Lennox-Gastaut syndrome, and the second on ...
22 Dec 2008 20:30:32
FDA Approved Drugs During 2008 - eMaxHealth.com
FDA Approved Drugs During 2008 eMaxHealth.com, NC - Banzel ( rufinamide ); For the treatment of seizures associated with Lennox-Gastaut syndrome in pediatrics and adults; Eisai; Approved November 2008 28. ...